Faculty profile

Maureen Trudeau

ResearcherPhysicsToronto Metropolitan University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Toronto Metropolitan University directory, so their courses and email address may be missing. Find their university profile.

Maureen Trudeau

Researcher

Physics

Health Sciences

Toronto Metropolitan University

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
32 publications in the last five years, latest in 2026.
Senior (last) author on 5 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2018.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

1,138

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cancer Imaging Cancer Treatment Monitoring Machine Learning Photoacoustic Imaging Therapy Response Utrasound Imaging

Latest papers

Health-related quality of life in breast cancer measured with EQ-5D-5L.
Journal of patient-reported outcomes · 2026
Reduced Survival Outcomes in Socioeconomically Disadvantaged Women With HER2-Negative Breast Cancer Undergoing Chemotherapy in Canada
Clinical Breast Cancer · 2026 · senior author
Using the Edmonton Symptom Assessment System (ESAS) to Describe Symptom Burden Associated with Breast Cancer and Related Treatments: A Cross-Sectional Study.
Current oncology (Toronto, Ont.) · 2025

All 92 publications

Latest funding

Ultrasound Platform for A Priori Therapy Response Prediction
CIHR · 2018 · Principal investigator
$453,500
Ultrasound-Stimulated Microbubble Enhancement of Tumour Radiation Response
CIHR · 2018 · Co-investigator
$795,600
Quantitative Ultrasound for A Priori Breast Cancer Chemoerthapy Response Prediction
CIHR · 2018 · Co-investigator
$598,995

All 4 grants and awards

92 publications.

Health-related quality of life in breast cancer measured with EQ-5D-5L.

Torres S, Trudeau M, Liu G, Mitsakakis N, Bayoumi AM

Journal of patient-reported outcomes2026

DOI: 10.1186/s41687-026-01044-x PMID: 41862778

Reduced Survival Outcomes in Socioeconomically Disadvantaged Women With HER2-Negative Breast Cancer Undergoing Chemotherapy in Canada

Giffoni M M Mata D, Fernandes I, Smith-Uffen M, Browne C, Sambhi R, Gehlaut S, Pezo RC, Chan KKW, Menjak I, Eisen A

Clinical Breast Cancer2026Senior author

DOI: 10.1016/j.clbc.2026.02.015

Using the Edmonton Symptom Assessment System (ESAS) to Describe Symptom Burden Associated with Breast Cancer and Related Treatments: A Cross-Sectional Study.

Torres S, Trudeau M, Liu G, Mitsakakis N, Bayoumi AM

Current oncology (Toronto, Ont.)2025

DOI: 10.3390/curroncol32110598 PMID: 41294659

Early mortality in patients with cancer and COVID-19 infection treated with immunotherapy.

Raphael J, Le B, Singh S, Blanchette P, Trudeau M, Lam M, Cheung M

BMC cancer2025

DOI: 10.1186/s12885-025-14318-2 PMID: 40405109

Impact of geriatric assessment on decision-making for adjuvant chemotherapy in older patients with breast cancer.

Menjak IB, Campos K, Hossain N, Zhang L, Mehta R, Trudeau M

Journal of geriatric oncology2025Senior author

DOI: 10.1016/j.jgo.2025.102260 PMID: 40449077

Prediction of Chemotherapy Response in Locally Advanced Breast Cancer Patients at Pre-Treatment Using CT Textural Features and Machine Learning: Comparison of Feature Selection Methods

Moslemi A, Osapoetra LO, Dasgupta A, Halstead S, Alberico D, Trudeau M, Gandhi S, Eisen A, Wright F, Look-Hong N

Tomography20255 citations

DOI: 10.3390/tomography11030033

Validation of a Quantitative Ultrasound Texture Analysis Model for Early Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer: A Prospective Serial Imaging Study

Moore-Palhares D, Sannachi L, Chan AW, Dasgupta A, DiCenzo D, Gandhi S, Pezo R, Eisen A, Warner E, Wright F

Cancers20255 citations

DOI: 10.3390/cancers17152594

Development of a framework on the incorporation of real-world evidence (RWE) into cancer drug funding decisions in Canada: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration

Chan KK-W, Takhar P, Evans WK, Mercer RE, Denburg A, Beca J, Muñoz C, Gavura S, Cheung WY, Hoch J

BMJ Open20254 citations

DOI: 10.1136/bmjopen-2024-096286

Validation of Quantitative Ultrasound and Texture Derivative Analyses-Based Model for Upfront Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer

Chan AW, Sannachi L, Moore-Palhares D, Dasgupta A, Gandhi S, Pezo R, Eisen A, Warner E, Wright FC, Hong NL

Journal of Imaging20252 citations

DOI: 10.3390/jimaging11040109

Quantitative ultrasound imaging for predicting response and guiding personalized neoadjuvant chemotherapy in breast cancer: randomized phase 2 clinical trial results

Moore-Palhares D, Alberico D, Chan AW, DiCenzo D, Sannachi L, Dasgupta A, Yip J, Pena MLA, Gandhi S, Pezo R

npj Precision Oncology20252 citations

DOI: 10.1038/s41698-025-01134-x

Something wrong or missing on this profile? Suggest a correction

Maureen Trudeau

Research

Latest papers

Latest funding

Health-related quality of life in breast cancer measured with EQ-5D-5L.

Reduced Survival Outcomes in Socioeconomically Disadvantaged Women With HER2-Negative Breast Cancer Undergoing Chemotherapy in Canada

Using the Edmonton Symptom Assessment System (ESAS) to Describe Symptom Burden Associated with Breast Cancer and Related Treatments: A Cross-Sectional Study.

Early mortality in patients with cancer and COVID-19 infection treated with immunotherapy.

Impact of geriatric assessment on decision-making for adjuvant chemotherapy in older patients with breast cancer.

Prediction of Chemotherapy Response in Locally Advanced Breast Cancer Patients at Pre-Treatment Using CT Textural Features and Machine Learning: Comparison of Feature Selection Methods

Validation of a Quantitative Ultrasound Texture Analysis Model for Early Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer: A Prospective Serial Imaging Study

Development of a framework on the incorporation of real-world evidence (RWE) into cancer drug funding decisions in Canada: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration

Validation of Quantitative Ultrasound and Texture Derivative Analyses-Based Model for Upfront Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer

Quantitative ultrasound imaging for predicting response and guiding personalized neoadjuvant chemotherapy in breast cancer: randomized phase 2 clinical trial results

Ultrasound Platform for A Priori Therapy Response Prediction

Ultrasound-Stimulated Microbubble Enhancement of Tumour Radiation Response

Quantitative Ultrasound for A Priori Breast Cancer Chemoerthapy Response Prediction

Quantitative Ultrasound for A Priori Breast Cancer Chemotherapy Response Prediction

Frequent collaborators

Andrea Eisen

Andrea Eisen

Frances Wright

Nicole Look Hong

Arjun Sahgal

Ewa Szumacher

Mina Tadrous

Avram Denburg

Daniel Moore Freitas Palhares

Yvonne Bombard

Rossanna Pezo

Simron Singh

Stuart Peacock

Nicholas Mitsakakis

Geoffrey Liu

Stuart Peacock

Kenneth Deal

Michael Kolios

Greg Stanisz

Michael Kolios

Murray Krahn

Ying Meng

Nir Lipsman

Martin Yaffe

Melanie Powis

Sharon Nofech-Mozes

Eileen Rakovitch

Petros Pechlivanoglou

William Evans

Kullervo Hynynen

Eva Grunfeld

Benjamin Davidson

Rahim Moineddin

Kenneth Pritzker

Eleanor Pullenayegum

Martine Puts

Arun Seth

Terrence Sullivan

Gregory Czarnota

Jonathan Irish